In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROSĀ® testing platform to perform COVID-1...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...